Biểu đồ giá cổ phiếu ROIV
ROIV Cổ tức
Roivant Sciences Ltd
$35.39
0.74%
$0.25
Khi đóng cửa: Jul 06, 16:00:00 GMT-4
$35.9
1.44%
$0.5
Phiên trước giờ: Jul 07, 09:08:22 GMT-4
Quay lại
Roivant Sciences Ltd (ROIV) Cổ tức
Thống kê chính
Giá đóng cửa trước
$35.13
Giá mở cửa
$34.85
Phạm vi ngày
$34.83 - $35.9
Phạm vi 52 tuần
$10.7 - $35.9
Khối lượng
5.7M
Khối lượng trung bình
6.0M
Tỷ suất cổ tức
--
EPS (TTM)
-0.45
Vốn hóa thị trường
$25.8B
ROIV là gì?
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
